BUILT Biotechnologies, Inc.
BUILT Biotechnologies provides DNA Manufacturing-as-a-Service, delivering ready-to-use, sequence-perfect DNA molecules without requiring in-house assembly. Powered by its Regenerative DNA Assembly™ platform and validated fragment inventory, the company offers clonal plasmids, whole-plasmid synthesis, linear DNA for IVT templates, and pooled plasmid libraries. The service has achieved zero build failures to date and serves customers from top-10 pharma to university core facilities.
- Biotechnology
- Drug Discovery & Therapeutics
- Healthcare Technology
- Software Only
Funding
Founders
Founder details are not available yet.
Product
Problem
Researchers and companies in genome engineering and synthetic biology often spend significant time and resources assembling DNA fragments or sourcing them piecemeal, creating bottlenecks in development. The lack of a reliable, fast, and cost-effective supply of ready-to-use, sequence-perfect DNA molecules slows down research and therapeutic development.
Solution
BUILT Biotechnologies offers a DNA Manufacturing-as-a-Service platform that delivers ready-to-use molecules, eliminating the need for in-house assembly. Powered by its Regenerative DNA Assembly™ technology and a growing inventory of validated fragments, the company provides four product types: clonal plasmid DNA, whole-plasmid synthesis, sequence-perfect linear DNA, and pooled plasmid libraries. This approach ensures high fidelity, with zero build failures to date, and provides a domestic supply chain for reliable access. The service is designed to accelerate development timelines for a range of life science applications, from cell and gene therapy to RNA therapeutics and synthetic biology broadly. Customers can reserve manufacturing capacity through a secure ordering portal, and the company is expanding its manufacturing footprint to meet rising demand.
Target Audience
Primary customers are biopharmaceutical companies (including top-10 pharma), university core facilities, and startups with large-scale DNA construction needs for cell and gene therapy, RNA therapeutics, and synthetic biology.
Features
- Regenerative DNA Assembly™ platform that reuses validated fragments from the BUILT DNA Inventory to reduce cost and lead times
- Four product types: Clonal plasmid DNA in the Standard BUILT Backbone (SBB), Whole-Plasmid Synthesis (WPS), Sequence-Perfect Linear DNA (LD) for IVT templates, and Pooled Plasmid Libraries (PPL) for high-throughput discovery
- Capability to construct long and complex "unbuildable" DNA molecules with high fidelity, with zero build failures to date
- Secure ordering portal with the ability to reserve manufacturing capacity through the first quarter of 2026
- Expanded manufacturing capacity and headquarters relocation to North Fork Research Park to support increasing project volume